arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

NU SKIN ENTERPRISES, INC.

NUS
$4.63 ▼ -0.24 (-4.83%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
19 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Bullish
auto_awesome

Analytical Summary

NU SKIN ENTERPRISES, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $228.2M
Dividend Yield —
Revenue Growth -14.3% ↘
Op. Margin 4.4% ↗
ROIC 5.3% ↗
FCF / Share $0.93 ↘
Trailing P/E 1.4x
Price / Book 0.3x
FCF Yield 20.2%
Debt / Equity 0.25
info Valuation on last close. End-of-day price, Sep 23, 2026.

19-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.49B
↓ -14.3% —
Net Income Profit after all expenses
$160.20M
↑ +209.3% —
Operating Margin Operating profit as % of sales
4.4%
↑ +150.6% 41th
FCF / Share Free cash flow per share
$0.93
↓ -33.9% —
Long-Term Debt Long-term obligations
$204.19M
↓ -43.8% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↑
48
Returns ↑
86
Financial Health ↓
69
Cash Quality ↓
32

Dividend History

Dividend / share · sourced from SEC filings
$0.34 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 19 years · 71 quarters